IRIDEX Corporation (IRIX)

IRIDEX Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 30, 2023	Dec 31, 2022	Jan 1, 2022	Jan 2, 2021	Dec 28, 2019
Revenue	49.92	51.87	56.97	53.9	36.35	43.45
Revenue Growth (YoY)	-12.86%	-8.96%	5.69%	48.30%	-16.34%	1.99%
Cost of Revenue	29.6	30.06	31.6	31.07	20.79	25.51
Gross Profit	20.33	21.81	25.37	22.83	15.56	17.94
Selling, General & Admin	24.67	24.99	25.74	23.5	18.86	23.23
Research & Development	6.62	6.83	7.18	6.87	3.28	3.68
Operating Expenses	31.28	31.81	32.91	30.36	22.14	26.91
Operating Income	-10.96	-10.01	-7.54	-7.53	-6.58	-8.97
Other Expense / Income	-0.13	-0.53	-0.06	-2.35	-0.28	-0.21
Pretax Income	-10.83	-9.48	-7.48	-5.19	-6.3	-8.77
Income Tax	0.12	0.09	0.07	0.04	0.03	0.05
Net Income	-10.94	-9.57	-7.55	-5.23	-6.33	-8.81
Shares Outstanding (Basic)	16	16	16	15	14	14
Shares Outstanding (Diluted)	16	16	16	15	14	14
Shares Change	1.57%	1.19%	3.35%	11.41%	0.98%	12.36%
EPS (Basic)	-0.67	-0.59	-0.47	-0.34	-0.46	-0.64
EPS (Diluted)	-0.67	-0.59	-0.47	-0.34	-0.46	-0.64
Free Cash Flow	-5.62	-6.85	-9.81	8	-3.33	-8.04
Free Cash Flow Per Share	-0.35	-0.42	-0.61	0.52	-0.24	-0.59
Gross Margin	40.72%	42.04%	44.53%	42.36%	42.80%	41.29%
Operating Margin	-21.95%	-19.29%	-13.24%	-13.98%	-18.11%	-20.66%
Profit Margin	-21.92%	-18.45%	-13.25%	-9.69%	-17.41%	-20.28%
Free Cash Flow Margin	-11.26%	-13.21%	-17.21%	14.85%	-9.16%	-18.51%
EBITDA	-8.78	-7.45	-6.1	-3.48	-5.8	-8.08
EBITDA Margin	-17.58%	-14.36%	-10.70%	-6.45%	-15.95%	-18.59%
Depreciation & Amortization	2.05	2.03	1.38	1.71	0.5	0.69
EBIT	-10.83	-9.48	-7.48	-5.19	-6.3	-8.77
EBIT Margin	-21.69%	-18.28%	-13.13%	-9.62%	-17.34%	-20.17%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).